TC | 
Stat | 
Stk | 
Ins | 
Fil | 
+d | 
+w | 
+m | 
+q | 
+h | 
+y | 
avg | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -1 | -1 | 3 | 4 | 1 | -17 | -2 | 
| S | %wins | 100 | 67 | 0 | 33 | 67 | 67 | 56 | 
Filing Date | 
					T Date | 
					Ticker | 
					Issuer | Inc | 					Sector | 
					Ind | Industry |  
						Owner | 
						oSt | 
						Rel | 
						Title | 
					 
					T | 
					TVal | 
					Price | 
					L | 
					Qty | 
					oc | 
					Own | 
					H | 
					r2y | 
					r1y | 
					r6m | 
					r3m | 
					r6w | 
					r3w | 
					r7d | 
					r3d | 
					f1d | 
					f1w | 
					f1m | 
					f3m | 
					f6m | 
					f1y | 
				
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/06 17:11  | 9/15/06  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | CFO,Myla | M.d | 94 | 11.58 | 33 | 8 | 5 | D | 10 | 16 | -13 | 3 | 6 | 4 | 4 | 1 | -2 | -4 | 2 | -1 | -6 | -24 | |
9/19/06 17:11  | 9/15/06  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | CFO,Myla | S.d | -172 | 21.20 | 33 | -8 | -62 | 5 | D | 10 | 16 | -13 | 3 | 6 | 4 | 4 | 1 | -2 | -4 | 2 | -1 | -6 | -24 | 
11/4/05 17:21  | 11/3/05  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | VP,Corpo | M.dm | 1,373 | 10.17 | 33 | 135 | 5 | D | -17 | 19 | 20 | 9 | 8 | -2 | -8 | 1 | 0 | 1 | 3 | 8 | 11 | 3 | |
11/4/05 17:21  | 11/3/05  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | VP,Corpo | S.dm | -2,675 | 19.81 | 33 | -135 | -96 | 5 | D | -17 | 19 | 20 | 9 | 8 | -2 | -8 | 1 | 0 | 1 | 3 | 8 | 11 | 3 | 
8/29/03 16:31  | 8/27/03  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | VP,Corpo | M.d | 33 | 11.13 | 33 | 3 | 756 | 3 | D | 61 | 69 | 26 | 25 | 11 | 5 | 0 | -1 | 0 | 0 | 5 | 6 | -2 | -29 | 
8/29/03 16:31  | 8/27/03  | MYL | Mylan Laboratories Inc | PA | Health | Drug | Pharmaceutical Preparations | Sphar Gary | WV | O | VP,Corpo | S.d | -108 | 35.86 | 33 | -3 | -47 | 3 | D | 61 | 69 | 26 | 25 | 11 | 5 | 0 | -1 | 0 | 0 | 5 | 6 | -2 | -29 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |